Globe Newswire
FORM 8.3
PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1.KEY INFORMATION (a)Full name of discloser:Invesco Ltd. (b)Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)Name of offeror/offeree in... (continue reading...)Presentation and Live Webcast to be Held June 4, 2024, at 10:15 am ET
THE WOODLANDS, Texas, May 29, 2024 (GLOBE NEWSWIRE) -- Howard Hughes Holdings Inc. (NYSE: HHH) announced today that Chief Financial Officer Carlos Olea will participate in a presentation moderated by Alex Goldfarb from Piper Sandler at NAREIT's REITweek 2024 Investor Conference in New York City on Tuesday, June 4, 2024, at 10:15 am ET.
HHH's live presentation will be accessible via audio webcast... (continue reading...)
TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) (“Red Pine” or the “Company”) is pleased to announce the most recent assay results from 14 drill holes representing 4,105 metres (“m”) of drilling from the 2022-2024 resource expansion program at the Wawa Gold Project. Since the resource expansion drilling program began in 2021, Red Pine has now completed approximately 67,000 m of additional drilling in the... (continue reading...)
CEO Cameron Chell to Highlight the Role of Drones and Draganfly in the New Global Economic and Political Reality
Los Angeles, CA, May 29, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A), a leader in drone technology and unmanned aerial vehicle (UAV) solutions, will be participating in the Centurion One Los Angeles Summit, held at the Beverly Hills Hotel from June 5th to June 6th, 2024, in Beverly Hills, California.
The Centurion One Los... (continue reading...)
MALVERN, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that the Company will present at the 2024 BIO International Convention taking place in San Diego, CA from June 3 – 6, 2024.
During the conference, Ocugen’s leadership team will host meetings with potential partners and... (continue reading...)
More Globe Newswire
View Older Stories-
The Habit Burger Grill Opens Second Lancaster Location in Home State of California
-
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio for a potential value of $3 billion
-
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio for a potential value of $3 billion
-
Gildan Activewear Reports on Shareholders’ Voting Results
-
Sable Stakes Additional Ground Along the Perk Rocky Regional Trend in BC, Canada
-
Valore Update of Hatchet Lake Uranium Project
-
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
-
Host Hotels & Resorts Enters into Agreement to Acquire Turtle Bay Resort in Hawaii
-
Atea Pharmaceuticals to Present at the Jefferies Healthcare Conference
-
Augmedix Appoints Alex Stinard, M.D., as Chief Clinical AI Officer
-
ProKidney to Participate in the Jefferies Global Healthcare Conference
-
The Habit Burger Grill Opens New Drive-Thru in Fresno, Its Fifth Location in the California City
-
Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors
-
Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference
-
Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™
-
Kymera Therapeutics to Participate in Upcoming June Investor Conferences
-
Plum Teams Up with hireEZ to Improve Recruiting Outcomes Through Job Matching
-
Assertio Announces the Appointment of Brendan P. O’Grady as New CEO
-
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator
-
Plymouth Industrial REIT to Present at Nareit’s REITweek 2024
-
Lotus Technology Reports Unaudited First Quarter 2024 Financial Results
-
Bitfarms Responds to Unsolicited Proposal from Riot Platforms
-
Kynexis Appoints Esteemed Scientific Advisory Board Members to Advance Precision Therapeutics for Brain Diseases
-
Cielo Announces Appointment of New Auditor
-
Athira Pharma to Participate in Upcoming June Conferences
-
Dragonfly Energy to Participate in June 2024 Conferences
-
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
-
Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024
-
Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions
-
TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies
-
Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024
-
ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaking Oral Presentation at ENDO 2024
-
Invivyd to Present Data at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and 2024 American Transplant Congress (ATC)
-
OTC Markets Group Welcomes Verde Agritech Ltd. to OTCQX
-
Akero Therapeutics to Present at the Jefferies Global Healthcare Conference
-
OTC Markets Group Welcomes Marpai, Inc. to OTCQX
-
Balchem Corporation to Present at the Wells Fargo Industrials Conference on June 12, 2024
-
MediWound Reports First Quarter 2024 Financial Results and Provides Company Update
-
IGM Biosciences to Present at the Jefferies Healthcare Conference
-
Kymera Therapeutics to Participate in Upcoming June Investor Conferences
-
The Habit Burger Grill Opens New Drive-Thru in Fresno, Its Fifth Location in the California City
-
Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma
-
"Charm of Jiangsu" International Photography Project: Experiencing the Flavor of Happiness
-
"Charm of Jiangsu" International Photography Project: Experiencing the Flavor of Happiness
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - HARGREAVES LANSDOWN PLC - Ordinary Shares
-
Castellum, Inc. Announces Leadership Changes
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
-
Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides
-
Man Group PLC : Form 8.3 - Barratt Developments plc
